Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDI-320 in rosacea
NCT01828177Phase 2Unknown
- Sponsor
- PreCision Dermatology, Inc.
- Start
- Jun 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PDI-320 in rosacea, sponsored by PreCision Dermatology, Inc.. Status: unknown.
02
Drugs
PDI-320
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01828177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828177.